BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression
IntroductionBRAFV600E mutation (BRAFmut) is common in papillary thyroid cancer (PTC), and most patients have an excellent outcome. However, a TERT-promoter mutation (pTERTmut) in the presence of BRAFmut (BRAFmutpTERTmut) has been demonstrated to confer a more aggressive behavior to PTC. Lymphocytic...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-12-01
|
| シリーズ: | Frontiers in Endocrinology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1440722/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
